| Title |
Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, April 2021
|
| DOI | 10.2147/ndt.s290104 |
| Pubmed ID | |
| Authors |
Salome Landolt, Thomas Rosemann, Eva Blozik, Beat Brüngger, Carola A Huber |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 13% |
| Switzerland | 1 | 13% |
| Japan | 1 | 13% |
| Unknown | 5 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 37 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 16% |
| Student > Ph. D. Student | 4 | 11% |
| Student > Master | 3 | 8% |
| Professor | 2 | 5% |
| Student > Bachelor | 1 | 3% |
| Other | 6 | 16% |
| Unknown | 15 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 16% |
| Unspecified | 2 | 5% |
| Neuroscience | 2 | 5% |
| Economics, Econometrics and Finance | 2 | 5% |
| Other | 2 | 5% |
| Unknown | 16 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#1,248,839
of 25,387,668 outputs
Outputs from Neuropsychiatric Disease and Treatment
#162
of 3,131 outputs
Outputs of similar age
#34,566
of 453,673 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 53 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.